Odyssey Thera compounding profiling service
Using cutting-edge Protein-fragment Complementation Assay technology from Odyssey Thera, Lonza is able to offer profiling services that can shape and influence critical decisions about drug candidates.
This unique cell-wide analysis platform broadly addresses target classes, signalling pathways and cellular processes. Classify drugs by comparison to an extensive compound database defining MOA and predicting safety threats.
It features: analysis of drug activity for any target class or pathway across cellular systems; high-content/high-throughput data capture and analysis; in-depth data interpretation including comparison to an extensive database of known drugs and toxicants; improved decision making throughout the development process.
Suitable applications include: target validation, HTS, SAR testing, toxicity and drug safety screens and compound selectivity testing.
Phone: 1300 657508
Proteomics International PromarkerD LDT immunoassay (ELISA)
PromarkerD is a blood test designed to assess an individual's risk of developing chronic...
Cytek cFluor Human B Cell Monitoring Kit
The Cytek cFluor Human B Cell Monitoring Kit identifies B cell subsets in human peripheral blood...
Primerdesign exsig Mag RapidBead Pro Extraction Kit
Primerdesign's exsig Mag RapidBead Pro Extraction Kit is a next-generation, magnetic...

